Cargando…

MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools

Neurofibromatosis type 2 is a neurogenetic disorder with an incidence of about 1:33.000. Hallmarks are bilateral benign vestibular schwannomas, which can lead to deafness or brainstem compression. Volumetric tumor measurements are essential to assess the efficacy of new therapies. We present a stati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kollmann, Philipp, Mautner, Victor-Felix, Koeppen, Johannes, Wenzel, Ralph, Friedman, Jan M., Salamon, Johannes, Farschtschi, Said
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360562/ https://www.ncbi.nlm.nih.gov/pubmed/32665659 http://dx.doi.org/10.1038/s41598-020-68489-y

Ejemplares similares

Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Non-optic glioma in adults and children with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2017)

Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2018)

Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
por: Well, Lennart, et al.
Publicado: (2021)

Impact of Surgery on Long-Term Results of Hearing in Neurofibromatosis Type-2 Associated Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2019)

Age at Onset and Presenting Symptoms of Neurofibromatosis Type 2 as Prognostic Factors for Clinical Course of Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2020)

New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)

Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients
por: Gugel, Isabel, et al.
Publicado: (2019)

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
por: Well, Lennart, et al.
Publicado: (2020)

Alterations in brain morphology by MRI in adults with neurofibromatosis 1
por: Wang, Su, et al.
Publicado: (2021)

Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1
por: Ristow, Inka, et al.
Publicado: (2022)

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
por: Stivaros, Stavros M, et al.
Publicado: (2015)

A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2
por: Abeshi, Andi, et al.
Publicado: (2023)

Long-term Follow-up and Histological Correlation of Peripheral Nervous System Alterations in Neurofibromatosis Type 2
por: Godel, Tim, et al.
Publicado: (2021)

Clinical characterization of children and adolescents with NF1 microdeletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2020)

The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas
por: Lustgarten, Leonardo
Publicado: (2013)

Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients
por: FUJII, Masazumi, et al.
Publicado: (2020)

Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021)

Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
por: Farschtschi, Said, et al.
Publicado: (2016)

Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma
por: Shinya, Yuki, et al.
Publicado: (2019)

Ipsilateral Vestibular Schwannoma after Cochlear Implantation
por: Tüpker, S., et al.
Publicado: (2022)

COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma
por: Behling, Felix, et al.
Publicado: (2021)

Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
por: Kim, Junhyung, et al.
Publicado: (2022)

Management of Sporadic Vestibular Schwannomas in Children—Volumetric Analysis and Clinical Outcome Assessment
por: Zipfel, Julian, et al.
Publicado: (2022)

White matter is increased in the brains of adults with neurofibromatosis 1
por: Wang, Su, et al.
Publicado: (2022)

Comparison of Surgeons’ Assessment of the Extent of Vestibular Schwannoma Resection with Immediate Post Operative and Follow-Up Volumetric MRI Analysis
por: Mahboubi, Hossein, et al.
Publicado: (2023)

Cochlear Implantation in Patients with Neurofibromatosis Type 2 and Patients with Vestibular Schwannoma in the Only Hearing Ear
por: Celis-Aguilar, Erika, et al.
Publicado: (2012)

Corrigendum: Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
por: Kim, Junhyung, et al.
Publicado: (2022)

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis
por: Li, Ka-Loh, et al.
Publicado: (2016)

A comparison of semi-automated volumetric vs linear measurement of small vestibular schwannomas
por: MacKeith, Samuel, et al.
Publicado: (2018)

Metachronous schwannoma in the colon with vestibular schwannoma
por: Jung, Eun-Joo, et al.
Publicado: (2014)

Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments
por: Chen, Li-Hua, et al.
Publicado: (2018)

NFB-08. PHASE II STUDY OF AXITINIB IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS
por: Phadnis, Sheetal, et al.
Publicado: (2020)

Coexistent vestibular schwannoma and meningioma in a patient without neurofibromatosis: A case report and review of literature
por: Zhao, Li-Yan, et al.
Publicado: (2021)

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients
por: Webb, M J, et al.
Publicado: (2023)

Does vestibular function correlate with objective MRI findings after vestibular schwannoma surgery?
por: Balatková, Zuzana, et al.
Publicado: (2023)

Segmental neurofibromatosis with deep schwannoma
por: Smith, Wallace A., et al.
Publicado: (2016)

Maximum diameter versus volumetric assessment for the response evaluation of vestibular schwannomas receiving stereotactic radiotherapy
por: Choi, Youngmin, et al.
Publicado: (2018)

Combined translabyrinthine, anterior petrosal approach for resection of collision vestibular schwannoma and petrous apex meningioma in neurofibromatosis type 2, with auditory brainstem implant placement
por: Khan, Usman A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b66j6js3hfc5odq88koearlpke